It is reported that loss of Nrf2 in an oncogenic context-dependent manner can enhance cellular plasticity and motility, in part by using TGF-β/Smad signaling [17], and Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of Bach1 [18]. Here, NFE2L2 is linked to lung carcinoma.